{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where agency_id = \"FDA\" and docket_id = \"FDA-2010-N-0002\" sorted by posted_date descending", "rows": [["FDA-2010-N-0002-0095", "FDA", "FDA-2010-N-0002", "New Animal Drugs: Change of Sponsor's Name and Address; Corrections", "Rule", "NCR-Notice of Correction", "2011-03-24T04:00:00Z", 2011, 3, "2011-03-24T04:00:00Z", null, "2011-03-24T13:39:40Z", "2011-6795", 0, 0, "0900006480c0f8fd"], ["FDA-2010-N-0002-0097", "FDA", "FDA-2010-N-0002", "Animal Drugs, Feeds, and Related Products; Withdrawal of Approval of  New Animal Drug Applications; Aklomide; Levamisole Hydrochloride; Nitromide and Sulfanitran; Roxarsone; Correction", "Rule", "NCR-Notice of Correction", "2011-03-24T04:00:00Z", 2011, 3, "2011-03-24T04:00:00Z", null, "2011-03-24T13:46:28Z", "2011-6790", 0, 0, "0900006480c0fd1e"], ["FDA-2010-N-0002-0096", "FDA", "FDA-2010-N-0002", "New Animal Drugs for Use in Animal Feeds: Florfenicol; Correction", "Rule", "NCR-Notice of Correction", "2011-03-24T04:00:00Z", 2011, 3, "2011-03-24T04:00:00Z", null, "2011-03-24T13:42:25Z", "2011-6789", 0, 0, "0900006480c0fd16"], ["FDA-2010-N-0002-0098", "FDA", "FDA-2010-N-0002", "Certain Other Dosage Form New Animal Drugs: Detomidine; Correction", "Rule", "NCR-Notice of Correction", "2011-03-24T04:00:00Z", 2011, 3, "2011-03-24T04:00:00Z", null, "2011-03-24T13:48:54Z", "2011-06791", 0, 0, "0900006480c0fd2a"], ["FDA-2010-N-0002-0094", "FDA", "FDA-2010-N-0002", "Freedom of Information - NADA 141-312 - Labeling", "Supporting & Related Material", "FOIS-Freedom of Information Summary", "2011-01-21T05:00:00Z", 2011, 1, null, null, "2011-01-21T15:18:02Z", null, 0, 0, "0900006480bcfc71"], ["FDA-2010-N-0002-0093", "FDA", "FDA-2010-N-0002", "Freedom Of Information Summary - NADA 141-312 - HEXASOL Injection Oxytetracycline and Flunixin Meglumine Injectable Solution Beef and Non-Lactating Dairy Cattle", "Supporting & Related Material", "FOIS-Freedom of Information Summary", "2011-01-20T05:00:00Z", 2011, 1, null, null, "2011-01-20T14:24:04Z", null, 0, 0, "0900006480bce7ff"], ["FDA-2010-N-0002-0092", "FDA", "FDA-2010-N-0002", "Implantation or Injectable Dosage Form New Animal Drugs: Oxytetracycline and Flunixin", "Rule", "NFR-Notice of Final Rule", "2011-01-20T05:00:00Z", 2011, 1, "2011-01-20T05:00:00Z", null, "2011-01-20T14:05:26Z", "2011-01040", 0, 0, "0900006480bce9e7"], ["FDA-2010-N-0002-0091", "FDA", "FDA-2010-N-0002", "New Animal Drugs: Change of Sponsor", "Rule", "NFR-Notice of Final Rule", "2011-01-18T05:00:00Z", 2011, 1, "2011-01-18T05:00:00Z", null, "2011-01-18T14:54:02Z", "2011-904", 0, 0, "0900006480bcce2d"], ["FDA-2010-N-0002-0090", "FDA", "FDA-2010-N-0002", "New Animal Drugs: Follicle Stimulating Hormone; Change of Sponsor", "Rule", "NFR-Notice of Final Rule", "2011-01-18T05:00:00Z", 2011, 1, "2011-01-18T05:00:00Z", null, "2011-01-18T14:51:10Z", "2011-909", 0, 0, "0900006480bccd28"], ["FDA-2010-N-0002-0088", "FDA", "FDA-2010-N-0002", "New Animal Drugs: Deslorelin", "Rule", "NFR-Notice of Final Rule", "2010-12-28T05:00:00Z", 2010, 12, "2010-12-28T05:00:00Z", null, "2010-12-28T15:43:43Z", "2010-32554", 0, 0, "0900006480bc0c09"], ["FDA-2010-N-0002-0089", "FDA", "FDA-2010-N-0002", "Freedom of Information Summary - [NADA-141-319] - Deslorelin acetate Injection Horses/Estrous mares", "Other", "FOIS-Freedom of Information Summary (No Federal Register Publication)", "2010-12-28T05:00:00Z", 2010, 12, "2010-12-28T05:00:00Z", null, "2010-12-28T16:01:31Z", null, 0, 0, "0900006480bc13dc"], ["FDA-2010-N-0002-0087", "FDA", "FDA-2010-N-0002", "New Animal Drugs; Change of Sponsor's Address", "Rule", "NFR-Notice of Final Rule", "2010-12-21T05:00:00Z", 2010, 12, "2010-12-21T05:00:00Z", null, "2010-12-21T14:31:22Z", "2010-31952", 0, 0, "0900006480bbcc1e"], ["FDA-2010-N-0002-0085", "FDA", "FDA-2010-N-0002", "New Animal Drugs: Mupirocin", "Rule", "NFR-Notice of Final Rule", "2010-12-20T05:00:00Z", 2010, 12, "2010-12-20T05:00:00Z", null, "2010-12-20T14:51:05Z", "2010-31870", 0, 0, "0900006480bba052"], ["FDA-2010-N-0002-0086", "FDA", "FDA-2010-N-0002", "Freedom of Information Summary - [ANADA-200-457]", "Supporting & Related Material", "FOIS-Freedom of Information Summary", "2010-12-20T05:00:00Z", 2010, 12, null, null, "2010-12-20T15:04:13Z", null, 0, 0, "0900006480bba73b"], ["FDA-2010-N-0002-0082", "FDA", "FDA-2010-N-0002", "Freedom of Information Summary [ANADA 200-473 Pharmasin Soluble (tylosin tartrate)]", "Supporting & Related Material", "FOIS-Freedom of Information Summary", "2010-12-08T05:00:00Z", 2010, 12, null, null, "2010-12-08T15:55:03Z", null, 0, 0, "0900006480bb1b46"], ["FDA-2010-N-0002-0081", "FDA", "FDA-2010-N-0002", "Oral Dosage Form New Animal Drugs: Tylosin", "Rule", "NFR-Notice of Final Rule", "2010-12-08T05:00:00Z", 2010, 12, "2010-12-08T05:00:00Z", null, "2010-12-08T15:43:21Z", "2010-30814", 0, 0, "0900006480bb1e23"], ["FDA-2010-N-0002-0084", "FDA", "FDA-2010-N-0002", "Freedom of Information Summary [ANADA 200-061- FLU-NIX (flunixin meglumine) Injectable Solution)]", "Supporting & Related Material", "FOIS-Freedom of Information Summary", "2010-12-08T05:00:00Z", 2010, 12, null, null, "2010-12-08T16:26:07Z", null, 0, 0, "0900006480bb1b67"], ["FDA-2010-N-0002-0083", "FDA", "FDA-2010-N-0002", "Implantation or Injectable Dosage Form New Animal Drugs: Flunixin", "Rule", "NFR-Notice of Final Rule", "2010-12-08T05:00:00Z", 2010, 12, "2010-12-08T05:00:00Z", null, "2010-12-08T16:18:02Z", "2010-30769", 0, 0, "0900006480bb1ea7"], ["FDA-2010-N-0002-0080", "FDA", "FDA-2010-N-0002", "New Animal Drugs: Change of Sponsor's Name and Address", "Rule", "NFR-Notice of Final Rule", "2010-11-26T05:00:00Z", 2010, 11, "2010-11-26T05:00:00Z", null, "2024-11-07T22:30:37Z", "2010-29693", 1, 0, "0900006480ba43cf"], ["FDA-2010-N-0002-0079", "FDA", "FDA-2010-N-0002", "Intramammary Dosage Form New Animal Drugs: Cloxacillin Benzathine", "Rule", "NFR-Notice of Final Rule", "2010-11-22T05:00:00Z", 2010, 11, "2010-11-22T05:00:00Z", null, "2024-11-07T22:25:26Z", "2010-29326", 1, 0, "0900006480ba0922"], ["FDA-2010-N-0002-0078", "FDA", "FDA-2010-N-0002", "New Animal Drugs; Change of Sponsor: Sulfadiazine and Pyrimethamine Suspension", "Rule", "NFR-Notice of Final Rule", "2010-11-15T05:00:00Z", 2010, 11, null, null, "2010-11-15T17:45:37Z", "2010-28549", 0, 0, "0900006480b88cdb"], ["FDA-2010-N-0002-0077", "FDA", "FDA-2010-N-0002", "New Animal Drugs; Change of Sponsors Name", "Rule", "CEP-Certificate Extending Patent Term", "2010-11-10T05:00:00Z", 2010, 11, "2010-11-10T05:00:00Z", null, "2010-11-10T15:57:56Z", "2010-28307", 0, 0, "0900006480b86258"], ["FDA-2010-N-0002-0075", "FDA", "FDA-2010-N-0002", "Oral Dosage Form New Animal Drugs: Domperidone", "Rule", "NFR-Notice of Final Rule", "2010-11-01T04:00:00Z", 2010, 11, null, null, "2010-11-01T15:15:29Z", "2010-27524", 0, 0, "0900006480b7c883"], ["FDA-2010-N-0002-0076", "FDA", "FDA-2010-N-0002", "Freedom of Information Summary - EQUIDONE Gel [NADA-141-314] Domperidone", "Supporting & Related Material", "FOIS-Freedom of Information Summary", "2010-11-01T04:00:00Z", 2010, 11, null, null, "2010-11-01T16:05:49Z", null, 0, 0, "0900006480b7d0ab"], ["FDA-2010-N-0002-0074", "FDA", "FDA-2010-N-0002", "New Animal Drugs: Change of Sponsor; Monensin Blocks", "Rule", "NFR-Notice of Final Rule", "2010-10-28T04:00:00Z", 2010, 10, null, null, "2010-10-28T15:36:14Z", "2010-27287", 0, 0, "0900006480b79676"], ["FDA-2010-N-0002-0073", "FDA", "FDA-2010-N-0002", "Animal Drugs, Feeds, and Related Products; Withdrawals of Approvals of New Animal Drug Applications: Aklomide; Levamisole Hydrochloride; Nitromide and Sulfanitran", "Rule", "NFR-Notice of Final Rule", "2010-10-26T04:00:00Z", 2010, 10, null, null, "2010-10-26T14:48:15Z", "2010-27011", 0, 0, "0900006480b7753a"], ["FDA-2010-N-0002-0071", "FDA", "FDA-2010-N-0002", "Certain Other Dosage Form New Animal Drugs: Progesterone Intravaginal Inserts", "Rule", "NFR-Notice of Final Rule", "2010-10-14T04:00:00Z", 2010, 10, null, null, "2010-10-14T17:22:27Z", "2010-25893", 0, 0, "0900006480b6eed0"], ["FDA-2010-N-0002-0072", "FDA", "FDA-2010-N-0002", "Progesterone NADA 141-200 - Freedom of Information Summary", "Supporting & Related Material", "FOIS-Freedom of Information Summary", "2010-10-14T04:00:00Z", 2010, 10, null, null, "2010-10-14T17:39:37Z", null, 0, 0, "0900006480b6f3b2"], ["FDA-2010-N-0002-0070", "FDA", "FDA-2010-N-0002", "Implantation or Injectable Dosage Form New Animal Drugs; Ceftiofur Crystalline Free Acid", "Other", "FOIS-Freedom of Information Summary (No Federal Register Publication)", "2010-10-12T04:00:00Z", 2010, 10, "2010-10-12T04:00:00Z", null, "2010-10-12T15:38:15Z", null, 0, 0, "0900006480b6d1c7"], ["FDA-2010-N-0002-0069", "FDA", "FDA-2010-N-0002", "Implantation and Injectable Dosage Form New Animal Drugs: Ceftiofur Crystalline Free Acid; Technical Amendment", "Rule", "NFR-Notice of Final Rule", "2010-10-12T04:00:00Z", 2010, 10, "2010-10-12T04:00:00Z", null, "2010-10-12T15:25:22Z", "2010-25527", 0, 0, "0900006480b6c491"], ["FDA-2010-N-0002-0066", "FDA", "FDA-2010-N-0002", "Implantation or Injectable Dosage Form New Animal Drugs; Dexmedetomidine", "Rule", "NFR-Notice of Final Rule", "2010-09-30T04:00:00Z", 2010, 9, "2010-09-30T04:00:00Z", null, "2010-09-30T15:28:17Z", "2010-24494", 0, 0, "0900006480b64109"], ["FDA-2010-N-0002-0067", "FDA", "FDA-2010-N-0002", "Freedom of Information Summary [NADA 141-267 Dexdomitor (dexmedetomidine hydrochloride) sterile injectable solution cats]", "Supporting & Related Material", "FOIS-Freedom of Information Summary", "2010-09-30T04:00:00Z", 2010, 9, null, null, "2010-09-30T15:37:30Z", null, 0, 0, "0900006480b64614"], ["FDA-2010-N-0002-0068", "FDA", "FDA-2010-N-0002", "New Animal Drugs for Use in Animal Feeds; Melengestrol", "Rule", "NFR-Notice of Final Rule", "2010-09-30T04:00:00Z", 2010, 9, "2010-09-30T04:00:00Z", null, "2010-09-30T15:42:59Z", "2010-24480", 0, 0, "0900006480b64158"], ["FDA-2010-N-0002-0064", "FDA", "FDA-2010-N-0002", "Implantation and Injectable Dosage Form New Animal Drugs: Firocoxib", "Rule", "NFR-Notice of Final Rule", "2010-09-28T04:00:00Z", 2010, 9, "2010-09-28T04:00:00Z", null, "2010-09-28T14:58:35Z", "2010-24254", 0, 0, "0900006480b62263"], ["FDA-2010-N-0002-0065", "FDA", "FDA-2010-N-0002", "Freedom of Information Summary - EQUIOXX Injection [NADA-141-313] Firocoxib", "Supporting & Related Material", "FOIS-Freedom of Information Summary", "2010-09-28T04:00:00Z", 2010, 9, null, null, "2010-09-28T16:22:04Z", null, 0, 0, "0900006480b620ce"], ["FDA-2010-N-0002-0063", "FDA", "FDA-2010-N-0002", "Animal Drugs, Feeds, and Related Products; Withdrawals of Approvals of New Animal Drug Applications: Chloramphenicol; Lincomycin;Pyrantel Tartrate; and Tylosin Phosphate and Sulfamethazine", "Rule", "NFR-Notice of Final Rule", "2010-09-14T04:00:00Z", 2010, 9, null, null, "2010-09-14T15:22:40Z", "2010-22808", 0, 0, "0900006480b4ea9e"], ["FDA-2010-N-0002-0062", "FDA", "FDA-2010-N-0002", "Ophthalmic and Topical Dosage Form New Animal Drugs: Gentamicin and Betamethasone Ophthalmic Solution; Technical Amendment", "Rule", "NFR-Notice of Final Rule", "2010-09-08T04:00:00Z", 2010, 9, "2010-09-08T04:00:00Z", null, "2010-09-09T15:50:59Z", "2010-22276", 0, 0, "0900006480b48200"], ["FDA-2010-N-0002-0061", "FDA", "FDA-2010-N-0002", "Oral Dosage Form New Animal Drugs: Tiamulin", "Rule", "NFR-Notice of Final Rule", "2010-09-08T04:00:00Z", 2010, 9, "2010-09-08T04:00:00Z", null, "2010-09-09T16:00:35Z", "2010-22277", 0, 0, "0900006480b481aa"], ["FDA-2010-N-0002-0059", "FDA", "FDA-2010-N-0002", "New Animal Drugs for Use in Animal Feed: Ractopamine", "Notice", "NFR-Notice of Final Rule", "2010-09-03T04:00:00Z", 2010, 9, "2010-09-03T04:00:00Z", null, "2010-09-03T15:18:04Z", null, 0, 0, "0900006480b44db9"], ["FDA-2010-N-0002-0056", "FDA", "FDA-2010-N-0002", "New Animal Drugs: Change of Sponsor's Name and Address", "Rule", "NFR-Notice of Final Rule", "2010-09-03T04:00:00Z", 2010, 9, "2010-09-03T04:00:00Z", null, "2010-09-03T14:51:56Z", "2010-22044", 0, 0, "0900006480b4490f"], ["FDA-2010-N-0002-0060", "FDA", "FDA-2010-N-0002", "Freedom of Information - [NADA 141-225] - Optaflexx plus Rumensin plus Tylan", "Supporting & Related Material", "FOIS-Freedom of Information Summary", "2010-09-03T04:00:00Z", 2010, 9, null, null, "2010-09-03T15:21:33Z", null, 0, 0, "0900006480b44dbc"], ["FDA-2010-N-0002-0055", "FDA", "FDA-2010-N-0002", "Freedom of Information - [NADA 141-229] - Resflor Gold", "Supporting & Related Material", "FOIS-Freedom of Information Summary", "2010-09-03T04:00:00Z", 2010, 9, null, null, "2010-09-03T14:48:53Z", null, 0, 0, "0900006480b44d3d"], ["FDA-2010-N-0002-0057", "FDA", "FDA-2010-N-0002", "New Animal Drugs; Change of Sponsor: Penicillin G Benzathine and Penicillin G Procaine Suspension; Penicillin G Procaine Aqueous Suspension", "Rule", "NFR-Notice of Final Rule", "2010-09-03T04:00:00Z", 2010, 9, "2010-09-03T04:00:00Z", null, "2010-09-03T15:04:07Z", "2010-22042", 0, 0, "0900006480b449d2"], ["FDA-2010-N-0002-0053", "FDA", "FDA-2010-N-0002", "Freedom of Information - [NADA 141-224] - Optaflexx plus Rumensin plus Tylan", "Supporting & Related Material", "FOIS-Freedom of Information Summary", "2010-09-03T04:00:00Z", 2010, 9, null, null, "2010-09-03T14:41:24Z", null, 0, 0, "0900006480b44d38"], ["FDA-2010-N-0002-0052", "FDA", "FDA-2010-N-0002", "New Animal Drugs for Use in Animal Feed: Ractopamine", "Rule", "NFR-Notice of Final Rule", "2010-09-03T04:00:00Z", 2010, 9, "2010-09-03T04:00:00Z", null, "2010-09-03T14:36:56Z", "2010-22071", 0, 0, "0900006480b444d4"], ["FDA-2010-N-0002-0054", "FDA", "FDA-2010-N-0002", "Implantation or Injectable Dosage Form New Animal Drugs: Florfenicol and Flunixin", "Rule", "NFR-Notice of Final Rule", "2010-09-03T04:00:00Z", 2010, 9, null, null, "2010-09-03T14:45:33Z", "2010-22039", 0, 0, "0900006480b444ef"], ["FDA-2010-N-0002-0058", "FDA", "FDA-2010-N-0002", "Oral Dosage Form New Animal Drugs: Praziquantel and Pyrantel", "Rule", "NFR-Notice of Final Rule", "2010-09-03T04:00:00Z", 2010, 9, "2010-09-03T04:00:00Z", null, "2010-09-03T15:07:38Z", "2010-22043", 0, 0, "0900006480b449d4"], ["FDA-2010-N-0002-0051", "FDA", "FDA-2010-N-0002", "New Animal Drugs; Changes of Sponsors; Withdrawals of Approvals of New Animal Drug Applications: Deslorelin Acetate; Dichlorophene and Toluene Capsules; Pyrantel Pamoate Suspension", "Rule", "CEP-Certificate Extending Patent Term", "2010-08-27T04:00:00Z", 2010, 8, "2010-08-27T04:00:00Z", null, "2010-08-27T13:34:20Z", "2010-21296", 0, 0, "0900006480b3c459"], ["FDA-2010-N-0002-0050", "FDA", "FDA-2010-N-0002", "Withdrawals of Approvals of New Animal Drug Applications: Dichlorophene and Toluene Capsules", "Notice", "NWL-Notice of Withdrawl", "2010-08-27T04:00:00Z", 2010, 8, "2010-08-27T04:00:00Z", null, "2010-08-27T15:03:53Z", "2010-21295", 0, 0, "0900006480b3c3b7"], ["FDA-2010-N-0002-0048", "FDA", "FDA-2010-N-0002", "Implantations or Injectable Dosages Form New Animal Drugs: Propofol", "Rule", "NFR-Notice of Final Rule", "2010-07-06T04:00:00Z", 2010, 7, null, null, "2010-07-06T15:44:47Z", "2010-16301", 0, 0, "0900006480b13970"], ["FDA-2010-N-0002-0049", "FDA", "FDA-2010-N-0002", "PROPOCLEAR (propofol) Injectable Cats and Dogs", "Supporting & Related Material", "SUP-Supplement (Supporting and Related Material)", "2010-07-06T04:00:00Z", 2010, 7, null, null, "2010-07-06T16:07:53Z", null, 0, 0, "0900006480b136d8"], ["FDA-2010-N-0002-0047", "FDA", "FDA-2010-N-0002", "Penicillin G Procaine Freedom of Information Summary  NADA 065-010, Spnsored by Norbrook Laboratories, Ltd.", "Supporting & Related Material", "N-Notice (Supporting and Related Material)", "2010-06-21T04:00:00Z", 2010, 6, null, null, "2010-10-29T01:10:46Z", null, 0, 0, "0900006480b071b4"], ["FDA-2010-N-0002-0046", "FDA", "FDA-2010-N-0002", "Approval of a Supplemental New Animal Drug Application: Penicillin G Procaine Suspension", "Notice", "N-Notice", "2010-06-21T04:00:00Z", 2010, 6, "2010-06-21T04:00:00Z", null, "2010-10-29T01:10:46Z", "2010-14865", 0, 0, "0900006480b06f57"], ["FDA-2010-N-0002-0045", "FDA", "FDA-2010-N-0002", "New Animal Drugs for Use in Animal Feeds: Florfenicol", "Rule", "NFR-Notice of Final Rule", "2010-06-17T04:00:00Z", 2010, 6, null, null, "2010-10-29T01:10:45Z", "2010-14611", 0, 0, "0900006480b03b6f"], ["FDA-2010-N-0002-0041", "FDA", "FDA-2010-N-0002", "Ophthalmic and Topical Dosage Form New Animal Drugs: Ivermectin Topical Solution", "Rule", "NFR-Notice of Final Rule", "2010-05-12T04:00:00Z", 2010, 5, "2010-05-12T04:00:00Z", null, "2010-05-12T13:53:44Z", "2010-11244", 0, 0, "0900006480aebea3"], ["FDA-2010-N-0002-0044", "FDA", "FDA-2010-N-0002", "Freedom of Information (FOI) Summary for  Orbax Oral Suspension (orbifloxacin) NADA 141-305 Sponsored by Intervet, Inc.", "Supporting & Related Material", "FOIS-Freedom of Information Summary", "2010-05-12T04:00:00Z", 2010, 5, null, null, "2010-05-12T14:31:24Z", null, 0, 0, "0900006480aeb8a8"], ["FDA-2010-N-0002-0039", "FDA", "FDA-2010-N-0002", "Implantation or Injectable Dosage Form New Animal Drugs: Ivermectin", "Rule", "NFR-Notice of Final Rule", "2010-05-12T04:00:00Z", 2010, 5, "2010-05-12T04:00:00Z", null, "2010-05-12T13:37:48Z", "2010-11282", 0, 0, "0900006480aebe42"], ["FDA-2010-N-0002-0043", "FDA", "FDA-2010-N-0002", "Oral Dosages Form New Animal Drugs: Orbifloxacin Suspension", "Rule", "NFR-Notice of Final Rule", "2010-05-12T04:00:00Z", 2010, 5, "2010-05-12T04:00:00Z", null, "2010-05-12T14:14:28Z", "2010-11245", 0, 0, "0900006480aebeee"], ["FDA-2010-N-0002-0042", "FDA", "FDA-2010-N-0002", "Freedom of Information (FOI) Summary for (Ivermectin) Privermectin ANADA 200-340 Sponsored by First Priority, Inc.", "Supporting & Related Material", "FOIS-Freedom of Information Summary", "2010-05-12T04:00:00Z", 2010, 5, null, null, "2010-05-12T14:33:59Z", null, 0, 0, "0900006480aeb859"], ["FDA-2010-N-0002-0040", "FDA", "FDA-2010-N-0002", "Freedom of Information (FOI) Summary for Ivermectin Injection ANADA 200-429 Sponsored by Sparhawk Laboratories, Inc.", "Supporting & Related Material", "FOIS-Freedom of Information Summary", "2010-05-12T04:00:00Z", 2010, 5, null, null, "2010-05-12T13:46:42Z", null, 0, 0, "0900006480aeb854"], ["FDA-2010-N-0002-0038", "FDA", "FDA-2010-N-0002", "Animal Drugs, Feeds, and Related Products: Withdrawal of Approval of a New Animal Drug Application; Buquinolate; Coumaphos", "Rule", "NFR-Notice of Final Rule", "2010-05-05T04:00:00Z", 2010, 5, "2010-05-05T04:00:00Z", null, "2010-05-05T18:21:18Z", "2010-10564", 0, 0, "0900006480ae7219"], ["FDA-2010-N-0002-0037", "FDA", "FDA-2010-N-0002", "Withdrawal of Approval of New Animal Drug Applications: Coumaphos; Novobiocin; Buquinolate and Lincomycin", "Notice", "NWL-Notice of Withdrawl", "2010-05-05T04:00:00Z", 2010, 5, "2010-05-05T04:00:00Z", null, "2012-09-13T19:32:02Z", "2010-10567", 0, 0, "0900006480ae714e"], ["FDA-2010-N-0002-0036", "FDA", "FDA-2010-N-0002", "Freedom Of Information (FOI) Summary - ANADA 200-446 Butorphine Veterinary Injection (Butorphanol tartrate, USP) Injectable Solution", "Supporting & Related Material", "FOIS-Freedom of Information Summary", "2010-04-29T04:00:00Z", 2010, 4, null, null, "2010-04-29T14:14:33Z", null, 0, 0, "0900006480ae353a"], ["FDA-2010-N-0002-0035", "FDA", "FDA-2010-N-0002", "Implantation or Injectable Dosage Form New Animal Drugs: Butorphanol", "Rule", "NFR-Notice of Final Rule", "2010-04-29T04:00:00Z", 2010, 4, null, null, "2010-04-29T14:05:53Z", "2010-09871", 0, 0, "0900006480ae39a6"], ["FDA-2010-N-0002-0034", "FDA", "FDA-2010-N-0002", "Norocillin Penicillin G Procaine Injectable Suspension (NADA 065-010) - Freedom of Information Summary", "Other", "FOIS-Freedom of Information Summary (No Federal Register Publication)", "2010-04-27T04:00:00Z", 2010, 4, null, null, "2010-04-27T19:56:00Z", null, 0, 0, "0900006480ae16d2"], ["FDA-2010-N-0002-0033", "FDA", "FDA-2010-N-0002", "Freedom Of Information Summary - [NADA 141-306 - Dormosed Gel Detomidine hydrochloride Oromucosal Gel Horses - Orion Corporation]", "Supporting & Related Material", "FOIS-Freedom of Information Summary", "2010-04-23T04:00:00Z", 2010, 4, null, null, "2010-04-23T15:17:21Z", null, 0, 0, "0900006480ade217"], ["FDA-2010-N-0002-0032", "FDA", "FDA-2010-N-0002", "Certain Other Dosage Form New Animal Drugs; Detomidine", "Rule", "NFR-Notice of Final Rule", "2010-04-23T04:00:00Z", 2010, 4, null, null, "2010-04-23T15:05:24Z", "2010-09371", 0, 0, "0900006480ade6c3"], ["FDA-2010-N-0002-0031", "FDA", "FDA-2010-N-0002", "Freedom Of Information (FOI) Summary - Heifiermax 500, Optaflexx and Rumensin", "Supporting & Related Material", "FOIS-Freedom of Information Summary", "2010-04-22T04:00:00Z", 2010, 4, null, null, "2010-04-22T15:25:24Z", null, 0, 0, "0900006480add4cd"], ["FDA-2010-N-0002-0030", "FDA", "FDA-2010-N-0002", "New Animal Drugs for Use in Animal Feeds: Melengestrol, Monensin, and Ractopamine", "Rule", "NFR-Notice of Final Rule", "2010-04-22T04:00:00Z", 2010, 4, null, null, "2010-04-22T13:40:34Z", "2010-09304", 0, 0, "0900006480adcfba"], ["FDA-2010-N-0002-0028", "FDA", "FDA-2010-N-0002", "New Animal Drugs: Change of Sponsor", "Rule", "NFR-Notice of Final Rule", "2010-04-20T04:00:00Z", 2010, 4, "2010-04-20T04:00:00Z", null, "2024-11-12T04:53:46Z", "2010-09057", 1, 0, "0900006480adba4f"], ["FDA-2010-N-0002-0029", "FDA", "FDA-2010-N-0002", "New Animal Drugs: Change of Sponsor", "Rule", "NFR-Notice of Final Rule", "2010-04-20T04:00:00Z", 2010, 4, "2010-04-20T04:00:00Z", null, "2024-11-12T04:53:58Z", "2010-09045", 1, 0, "0900006480adbad7"], ["FDA-2010-N-0002-0027", "FDA", "FDA-2010-N-0002", "Implantation or Injectable Dosage Form New Animal Drugs: Change of Sponsor; Propofol", "Rule", "NFR-Notice of Final Rule", "2010-04-19T04:00:00Z", 2010, 4, "2010-04-19T04:00:00Z", null, "2024-11-07T22:17:54Z", "2010-08945", 1, 0, "0900006480adaf52"], ["FDA-2010-N-0002-0026", "FDA", "FDA-2010-N-0002", "Freedom Of Information Summary [NADA 141-266] - POSATEX Otic Suspension Orbifloxcin, Mometasone Furate Monohydrate and Posaconazole, Suspenion Dogs", "Supporting & Related Material", "BKG-Background Material", "2010-04-01T04:00:00Z", 2010, 4, null, null, "2010-04-01T16:12:53Z", null, 0, 0, "0900006480acde2d"], ["FDA-2010-N-0002-0025", "FDA", "FDA-2010-N-0002", "Ophthalmic and Topical Dosage Form New Animal Drugs: Orbifloxacin, Mometasone Furoate Monohydrate, and Posaconazole Suspension", "Rule", "NFR-Notice of Final Rule", "2010-04-01T04:00:00Z", 2010, 4, null, null, "2010-04-01T16:05:18Z", "2010-07163", 0, 0, "0900006480ace19b"], ["FDA-2010-N-0002-0023", "FDA", "FDA-2010-N-0002", "Implantation or Injectable Dosage Form New Animal Drugs: Flunixin", "Rule", "NFR-Notice of Final Rule", "2010-03-19T04:00:00Z", 2010, 3, null, null, "2010-03-19T14:36:48Z", "2010-06038", 0, 0, "0900006480ac18f4"], ["FDA-2010-N-0002-0024", "FDA", "FDA-2010-N-0002", "Freedom Of Information Summary - [ANADA 200-489] - FLUNAZINE-S (flunixin meglumine) Injectable Solution", "Supporting & Related Material", "FOIS-Freedom of Information Summary", "2010-03-19T04:00:00Z", 2010, 3, null, null, "2010-03-19T14:44:01Z", null, 0, 0, "0900006480ac19f7"], ["FDA-2010-N-0002-0022", "FDA", "FDA-2010-N-0002", "Oral Dosage Form New Animal Drugs: Tetracycline Powder; Technical Amendment", "Rule", "NFR-Notice of Final Rule", "2010-03-18T04:00:00Z", 2010, 3, "2010-03-18T04:00:00Z", null, "2010-03-18T15:23:20Z", "2010-05925", 0, 0, "0900006480ac0362"], ["FDA-2010-N-0002-0020", "FDA", "FDA-2010-N-0002", "New Animal Drugs for Use in Animal Feeds: Zilpaterol", "Notice", "NFR-Notice of Final Rule", "2010-03-11T05:00:00Z", 2010, 3, "2010-03-11T05:00:00Z", null, "2010-03-11T17:47:38Z", null, 0, 0, "0900006480abb716"], ["FDA-2010-N-0002-0021", "FDA", "FDA-2010-N-0002", "Freedom Of Information Summary - [ANADA 200-479] - HAEIFERMAX 500 plus Zilmax (melengestrol acetate and zilpaterol hydrochride)", "Supporting & Related Material", "FOIS-Freedom of Information Summary", "2010-03-11T05:00:00Z", 2010, 3, null, null, "2010-03-11T18:09:07Z", null, 0, 0, "0900006480abb71d"], ["FDA-2010-N-0002-0018", "FDA", "FDA-2010-N-0002", "New Animal Drugs for Use in Animal Feeds: Zilpaterol", "Notice", "NFR-Notice of Final Rule", "2010-03-11T05:00:00Z", 2010, 3, "2010-03-11T05:00:00Z", null, "2010-03-11T15:56:32Z", null, 0, 0, "0900006480abb59e"], ["FDA-2010-N-0002-0019", "FDA", "FDA-2010-N-0002", "Freedom Of Information Summary - [ANADA 200-480] - HAEIFERMAX 500 plus Zilmax (melengestrol acetate and zilpaterol hydrochride)", "Supporting & Related Material", "FOIS-Freedom of Information Summary", "2010-03-11T05:00:00Z", 2010, 3, null, null, "2010-03-11T17:30:03Z", null, 0, 0, "0900006480abb5a0"], ["FDA-2010-N-0002-0016", "FDA", "FDA-2010-N-0002", "New Animal Drugs for Use in Animal Feeds: Zilpaterol", "Rule", "NFR-Notice of Final Rule", "2010-03-11T05:00:00Z", 2010, 3, null, null, "2010-03-11T15:33:43Z", "2010-05224", 0, 0, "0900006480abaf98"], ["FDA-2010-N-0002-0017", "FDA", "FDA-2010-N-0002", "Freedom Of Information Summary - [ANADA 200-483] - HAEIFERMAX 500 plus Zilmax (melengestrol acetate and zilpaterol hydrochride)", "Supporting & Related Material", "BKG-Background Material", "2010-03-11T05:00:00Z", 2010, 3, null, null, "2010-03-11T15:49:58Z", null, 0, 0, "0900006480abb097"], ["FDA-2010-N-0002-0014", "FDA", "FDA-2010-N-0002", "New Animal Drugs: Change of Sponsor", "Rule", "NFR-Notice of Final Rule", "2010-03-05T05:00:00Z", 2010, 3, null, null, "2010-03-09T14:28:56Z", "2010-04560", 0, 0, "0900006480ab5f5b"], ["FDA-2010-N-0002-0015", "FDA", "FDA-2010-N-0002", "Freedom of Information Summary Supplement New Animal Drug Application - [NADA 141-251 - Advantage Muti for Dogs - Bayer HealthCare LLC]", "Supporting & Related Material", "FOIS-Freedom of Information Summary", "2010-03-05T05:00:00Z", 2010, 3, null, null, "2010-03-05T19:55:18Z", null, 0, 0, "0900006480aaf84e"], ["FDA-2010-N-0002-0012", "FDA", "FDA-2010-N-0002", "Freedom of Information Summary Supplement New Animal Drug Application for Tilmicosin - [NADA 149-929 - Elanco Animal Health]", "Supporting & Related Material", "BKG-Background Material", "2010-03-02T05:00:00Z", 2010, 3, null, null, "2010-03-03T20:30:11Z", null, 0, 0, "0900006480ab214b"], ["FDA-2010-N-0002-0013", "FDA", "FDA-2010-N-0002", "New Animal Drugs for Use in Animal Feeds; Chlortetracycline", "Notice", "NFR-Notice of Final Rule", "2010-03-02T05:00:00Z", 2010, 3, null, null, "2010-03-02T17:55:52Z", "2010-04205", 0, 0, "0900006480ab1f1b"], ["FDA-2010-N-0002-0011", "FDA", "FDA-2010-N-0002", "Implantation or Injectable Dosage Form New Animal Drugs; Tilmicosin", "Notice", "NFR-Notice of Final Rule", "2010-03-02T05:00:00Z", 2010, 3, null, null, "2010-03-02T17:35:31Z", "2010-04206", 0, 0, "0900006480ab1ea5"], ["FDA-2010-N-0002-0010", "FDA", "FDA-2010-N-0002", "Bacitracin Zinc and Nicarbazin, ANADA 200-478, Albac 50 plus Nicarb; Freedom of Information (FOI) Summary", "Supporting & Related Material", "FOIS-Freedom of Information Summary", "2010-02-23T05:00:00Z", 2010, 2, null, null, "2010-02-23T14:39:57Z", null, 0, 0, "0900006480aab373"], ["FDA-2010-N-0002-0009", "FDA", "FDA-2010-N-0002", "New Animal Drugs for Use in Animal Feeds: Bacitracin Zinc; Nicarbazin", "Rule", "NFR-Notice of Final Rule", "2010-02-22T05:00:00Z", 2010, 2, "2010-02-22T05:00:00Z", null, "2010-02-23T13:57:08Z", "2010-03328", 0, 0, "0900006480aa9b3b"], ["FDA-2010-N-0002-0008", "FDA", "FDA-2010-N-0002", "Freedom of Information Summary - [141-301]- Ractopamine Hydrochloride and Monensin, USP Type A Medicated Arcticles to be used in the Manufacture of Type C Medicated Feeds Finishing Hen and Tom Turkeys", "Supporting & Related Material", "FOIS-Freedom of Information Summary", "2010-02-16T05:00:00Z", 2010, 2, null, null, "2010-02-17T17:02:48Z", null, 0, 0, "0900006480aa5817"], ["FDA-2010-N-0002-0007", "FDA", "FDA-2010-N-0002", "New Animal Drugs for Use in Animal Feeds: Ractopamine; Monensin", "Notice", "NFR-Notice of Final Rule", "2010-02-05T05:00:00Z", 2010, 2, "2010-02-05T05:00:00Z", null, "2010-02-17T05:05:20Z", "2010-02427", 0, 0, "0900006480a8e9ae"], ["FDA-2010-N-0002-0006", "FDA", "FDA-2010-N-0002", "Labeling of EXCEDE - [ NADA 141-209 - Freedom of Information ]", "Supporting & Related Material", "Freedom of Information Summary", "2010-02-03T05:00:00Z", 2010, 2, null, null, "2014-01-07T21:32:50Z", null, 0, 0, "0900006480a8bb21"], ["FDA-2010-N-0002-0005", "FDA", "FDA-2010-N-0002", "Labeling - [ NADA 141-298 - Freedom of Information ]; Surolan", "Supporting & Related Material", "Freedom of Information Summary", "2010-02-03T05:00:00Z", 2010, 2, null, null, "2014-01-07T21:29:16Z", null, 0, 0, "0900006480a8bb1f"], ["FDA-2010-N-0002-0003", "FDA", "FDA-2010-N-0002", "Ophthalmic and Topical Dosage Form New Animal Drugs; Miconazole, Polymixin B, and Prednisolone Suspension", "Notice", "Notice of Final Rule", "2010-01-29T05:00:00Z", 2010, 1, "2010-01-29T05:00:00Z", null, "2013-07-08T19:24:29Z", "2010-01794", 0, 0, "0900006480a870c7"], ["FDA-2010-N-0002-0002", "FDA", "FDA-2010-N-0002", "EXCEDE Sterile Suspension, Ceftiofur Crystalline Free Acid Horses - Freedom of Information Summary - [NADA-141-209]", "Supporting & Related Material", "Freedom of Information Summary", "2010-01-29T05:00:00Z", 2010, 1, null, null, "2014-01-07T21:31:43Z", null, 0, 0, "0900006480a86f5c"], ["FDA-2010-N-0002-0001", "FDA", "FDA-2010-N-0002", "Implantation or Injectable Dosage Form New Animal Drugs; Ceftiofur Crystalline Free Acid", "Notice", "Notice of Final Rule", "2010-01-29T05:00:00Z", 2010, 1, "2010-01-29T05:00:00Z", null, "2013-07-08T19:48:56Z", "2010-01790", 0, 0, "0900006480a87061"], ["FDA-2010-N-0002-0004", "FDA", "FDA-2010-N-0002", "Freedom of Information Summary - [NADA-141-298]", "Supporting & Related Material", "Freedom of Information Summary", "2010-01-29T05:00:00Z", 2010, 1, null, null, "2013-07-08T19:26:42Z", null, 0, 0, "0900006480a86f5e"]], "truncated": false, "filtered_table_rows_count": 98, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"agency_id\" = :p0 and \"docket_id\" = :p1 order by posted_date desc limit 101", "params": {"p0": "FDA", "p1": "FDA-2010-N-0002"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2010-N-0002", "results": [{"value": "FDA", "label": "FDA", "count": 98, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2010-N-0002", "selected": true}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2010-N-0002", "results": [{"value": "Rule", "label": "Rule", "count": 51, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2010-N-0002&document_type=Rule", "selected": false}, {"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 33, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2010-N-0002&document_type=Supporting+%26+Related+Material", "selected": false}, {"value": "Notice", "label": "Notice", "count": 11, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2010-N-0002&document_type=Notice", "selected": false}, {"value": "Other", "label": "Other", "count": 3, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2010-N-0002&document_type=Other", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2010-N-0002", "results": [{"value": 2010, "label": 2010, "count": 89, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2010-N-0002&posted_year=2010", "selected": false}, {"value": 2011, "label": 2011, "count": 9, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2010-N-0002&posted_year=2011", "selected": false}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2010-N-0002&_facet=subtype"}, {"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2010-N-0002&_facet=posted_month"}, {"name": "comment_start_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2010-N-0002&_facet=comment_start_date"}, {"name": "open_for_comment", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2010-N-0002&_facet=open_for_comment"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2010-N-0002&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2010-N-0002&_facet_date=comment_start_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2010-N-0002&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 56.613816996105015, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}